A study on mother-to-fetus/infant transmission of influenza A(H7N9) virus: Two case reports and a review of literature

Clinical Respiratory Journal

Volumn 12, Issue 11, 2018, Pages 2539-2545

  Wang, Jiajia ^a   Xu, Hua ^a   Mu, Chuanyong ^a   Chen, Cheng ^a   Guo, Lingchuan ^a   Chen, Liling ^b   Huang, Jian an ^a   Guo, Qiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Suzhou Center for Disease Prevention and Control   (China)

Author keywords

H7N9 virus; neuraminidase inhibitor; postpartum woman; pregnant woman; transplacental transmission

Indexed keywords

ANTIBIOTIC AGENT; MISOPROSTOL; OSELTAMIVIR; PERAMIVIR; CYCLOPENTANE DERIVATIVE; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; SIALIDASE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CLINICAL ARTICLE; FEMALE; FETUS; FETUS HEART; HEMAGGLUTINATION INHIBITION TEST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLUENZA A (H7N9); LEUKOCYTE; LYMPHOCYTE COUNT; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; THROAT CULTURE; VERTICAL TRANSMISSION; VIRUS IDENTIFICATION; ANTAGONISTS AND INHIBITORS; FATALITY; FETOMATERNAL TRANSFUSION; FETUS DEATH; GENETICS; INFANT; INFLUENZA; INFLUENZA A VIRUS (H7N9); ISOLATION AND PURIFICATION; MOTHER; PREGNANCY; PROCEDURES; SECONDARY PREVENTION; STANDARDS; TRANSMISSION; TREATMENT OUTCOME; VIROLOGY;

ADULT; CYCLOPENTANES; ENZYME INHIBITORS; FATAL OUTCOME; FEMALE; FETAL DEATH; FETUS; GUANIDINES; HUMANS; INFANT; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MATERNAL-FETAL EXCHANGE; MOTHERS; NEURAMINIDASE; OSELTAMIVIR; PREGNANCY; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 85055293484     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12953     Document Type: Article

References (31)

1. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet. 2007;370:1137-1145
2. Cetinkaya M, Ozkan H, Celebi S, Köksal N, Hacimustafaoğlu M. Human 2009 influenza A (H1N1) virus infection in a premature infant born to an H1N1-infected mother: placental transmission? Turk J Pediatr. 2011;53:441-444
3. Picone O, Bernabe-Dupont C, Vauloup-Fellous C, et al. A suspected case of in utero transmission of influenza A (H1N1) 2009. J Gynecol Obstet Biol Reprod (Paris). 2011;40:473-475
4. Valvi C, Kulkarni R, Kinikar A, Khadse S. 2009 H1N1 infection in a 1-day-old neonate. Indian J Med Sci. 2010;64:549-552
5. Vásquez RD, Chávez VM, Gamio IE, et al. Probable vertical transmission of the influenza virus A (H1N1): apropos of a case. Rev Peru Med Exp Salud Publica. 2010;27:466-469
6. Dulyachai W, Makkoch J, Rianthavorn P, et al. Perinatal pandemic (H1N1) 2009 infection. Thailand Emerg Infect Dis. 2010;16:343-344
7. Iuliano AD, Jang Y, Jones J, et al. Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic-China, October 2016-February 2017. MMWR Morb Mortal Wkly Rep. 2017;66:254-255
8. Ke C, Mok C, Zhu W, et al. Human infection with highly pathogenic avian influenza A(H7N9) virus. China Emerg Infect Dis. 2017;23:1332-1340
9. Guo Q, Zhao D, Dong F, et al. Delivery of fetus death with misoprostol in a pregnant woman with H7N9 avian influenza A virus pneumonia and ARDS. Crit Care. 2014;18:589
10. Raj RS, Bonney EA, Phillippe M. Influenza, immune system, and pregnancy. Reprod Sci. 2014;21:1434-1451
11. Louie JK, Jamieson DJ, Rasmussen SA. 2009 pandemic influenza A (H1N1) virus infection in postpartum women in California. Am J Obstet Gynecol. 2011;204(144):e1-e6
12. Hartert TV, Neuzil KM, Shintani AK, et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol. 2003;189:1705-1712
13. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303:1517-1525
14. Qi X, Cui L, Xu K, et al. Avian influenza A(H7N9) virus infection in pregnant woman, China, 2013. Emerg Infect Dis. 2014;20:333-334
15. Cui G, Diao H, Wei Y, et al. Immune influence of pregnancy on human H7N9 infection: a case report. Rev Port Pneumol. 2006;2015(21):157-162
16. Wang G, Zhou Y, Gong S, et al. A pregnant woman with avian influenza A(H7N9) virus pneumonia and ARDS managed with extracorporeal membrane oxygenation. Southeast Asian J Trop Med Public Health. 2015;46:444-448
17. Kanmaz HG, Erdeve O, Oğz SS, et al. Placental transmission of novel pandemic influenza a virus. Fetal Pediatr Pathol. 2011;30:280-285
18. Meijer WJ, Wensing AM, Bruinse HW, Nikkels PG. High rate of chronic villitis in placentas of pregnancies complicated by influenza A/H1N1 infection. Infect Dis Obstet Gynecol. 2014;2014: 1-5. https://doi.org/10.1155/2014/768380
19. Likos AM, Kelvin DJ, Cameron CM, Rowe T, Kuehnert MJ, Norris PJ. Influenza viremia and the potential for blood-borne transmission. Transfusion. 2007;47:1080-1088
20. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis. 2006;12:1638-1643
21. Yawn DH, Pyeatte JC, Joseph JM, Eichler SL, Garcia-Bunuel R. Transplacental transfer of influenza virus. JAMA. 1971;216:1022-1023
22. McGregor JA, Burns JC, Levin MJ, Burlington B, Meiklejohn G. Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. Am J Obstet Gynecol. 1984;149:856-859
23. Zheng S, Tang L, Gao H, et al. Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A(H7N9) virus. Clin Infect Dis. 2018;66:1054-1060
24. Meijer WJ, Bruinse HW, van den Broek MP, Kromdijk W, Wensing AM. Oseltamivir and its active metabolite cross the placenta at significant levels. Clin Infect Dis. 2012;54:1676-1677
25. Louie JK, Acosta M, Jamieson DJ, Honein MA California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010;362(1):27-35
26. Cantey JB, Bascik SL, Heyne NG, et al. Prevention of mother-to-infant transmission of influenza during the postpartum period. Am J Perinatol. 2013;30:233-240
27. Wang Y, Guo Q, Yan Z, et al. Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection. J Infect Dis. 2018;217:1708–1717
28. Donner B, Niranjan V, Hoffmann G. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data. Drug Saf. 2010;33:631-642
29. Morioka I, Nonoyama S, Tanaka-Taya K, et al. Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: safety of oseltamivir treatment. Scand J Infect Dis. 2012;44:605-609
30. Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ. 2009;181:55-58
31. Saito S, Minakami H, Nakai A, Unno N, Kubo T, Yoshimura Y. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009. Am J Obstet Gynecol. 2013;209:130e1-130e9